# Ceevra, Inc.

- Location (FDA's records): San Francisco, CA
- FDA decisions: 6 (2017–2026): 6 510(k) clearances
- Product codes: QIH (4), LLZ (2)
- 510(k) review time since 2016: median 95 days, against 140 for FDA's reviews in the same codes and years (4 of 6 faster)
- Predicates its devices cite: 6 (5 its own); citations of its devices by later devices: 12 (5 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Echopixel, Inc.: 1 (https://510kreport.com/company/echopixel)

## Firms that cite its devices most
- Aibolit Technologies, LLC: 2 (https://510kreport.com/company/aibolit-technologies)
- Avatar Medical: 1 (https://510kreport.com/company/avatar-medical)
- Intuitive Surgical, Inc.: 1 (https://510kreport.com/company/intuitive-surgical)
- Sentiar, Inc.: 1 (https://510kreport.com/company/sentiar)
- Medicalvr B.V.: 1 (https://510kreport.com/company/medicalvr)
- Aramis Global AI Consultancies, LLC: 1 (https://510kreport.com/company/aramis-global-ai-consultancies)

## Its most-cited devices
- K173274: Ceevra Reveal 2.0 (2018), cited by 6
- K222676: Ceevra Reveal 3 (2023), cited by 3
- K171356: Clarity Reveal (2017), cited by 1
- K233568: Ceevra Reveal 3+ (2023), cited by 1
- K243933: Ceevra Reveal 3+ (2025), cited by 1

## Recent decisions
- K261595: Ceevra Reveal 4 (Aug 25, 2026)
- K243933: Ceevra Reveal 3+ (Mar 4, 2025)
- K233568: Ceevra Reveal 3+ (Dec 5, 2023)
- K222676: Ceevra Reveal 3 (Apr 25, 2023)
- K173274: Ceevra Reveal 2.0 (Jul 10, 2018)
- K171356: Clarity Reveal (Aug 3, 2017)

Source page: https://510kreport.com/company/ceevra